Xueting Hu
- Molecular Biology top 10%
- Cancer Research top 2%
- Electrical and Electronic Engineering
- Oncology
- Epidemiology
- Topics
- RNA modifications and cancer (9 papers)Cancer-related molecular mechanisms research (8 papers)Advanced battery technologies research (8 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xueting Hu
58 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 1.1k
- Cancer Research 708
- Electrical and Electronic Engineering 303
- Oncology 173
- Epidemiology 136
Countries citing papers authored by Xueting Hu
This map shows the geographic impact of Xueting Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueting Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueting Hu more than expected).
Fields of papers citing papers by Xueting Hu
This network shows the impact of papers produced by Xueting Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueting Hu. The network helps show where Xueting Hu may publish in the future.
Co-authorship network of co-authors of Xueting Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Xueting Hu. A scholar is included among the top collaborators of Xueting Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueting Hu. Xueting Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 14 | |
| 6 | 54 | |
| 7 | 3 | |
| 8 | 13 | |
| 9 | 6 | |
| 10 | 7 | |
| 11 | 1 | |
| 12 | 107 | |
| 13 | METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancerbreakdown → | 276 |
| 14 | 8 | |
| 15 | 33 | |
| 16 | 70 | |
| 17 | 28 | |
| 18 | 139 | |
| 19 | 49 | |
| 20 | 26 |
About Xueting Hu
Xueting Hu is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 66 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and Advanced battery technologies research (8 papers). The work is most often cited by research in Cancer Research (708 citations), Nephrology (116 citations) and Molecular Biology (1.1k citations). Xueting Hu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Minghui Wang, Duoguang Wu, Xiaotian He, Xiang Xu, Luoquan Ao, Bingan Lu, Jiang Zhou, Wei Bao, Wei Xing and Wei Guo. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.